Wei-Chen Lin
Attending Psychiatrist, Department of Psychiatry, Taipei Veterans General Hospital
Data updated
Research Footprint
Wei-Chen Lin appears in 4 tracked papers (2016–2023), most studied alongside Ketamine and Placebo, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Suicidality.
Most-cited paper: Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression (205 citations).
Frequent co-authors: Tung-Ping Su, Mu-Hong Chen and Cheng-Ta Li.
Background & Research
Wei-Chen Lin, MD, is an attending psychiatrist at Taipei Veterans General Hospital in Taipei, Taiwan. He appears as a coauthor on several clinical trials and translational studies of low-dose ketamine for treatment-resistant depression, often in collaboration with National Yang Ming Chiao Tung University and related Taipei-based psychiatry programs. His publication record suggests a focus on rapid-acting antidepressant interventions and suicide-related outcomes.
Key Impact
He is a recurring coauthor on multiple ketamine trials in treatment-resistant depression, including studies on suicidal ideation and neuroimaging outcomes.
Collaboration Network
4 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Wei-Chen Lin is associated with.